Skip to main content

KBC Group NV

Position in BIIB — Biogen Inc.

CIK 1411133 Brussels, C9

Position in BIIB

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$60,205,550
+$17,179,467 QoQ
Shares Held
278,652
+18.7% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#61
of 1,037 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BIIB Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KBC Group NV holds $2,157,048,254 across 10 Drug Manufacturers - General names. BIIB ranks #9 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BIIB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,205,550 278,652
2026-03-31 $43,026,083 234,692
2025-12-31 $9,397,512 53,398
2025-09-30 $4,967,096 35,459
2025-06-30 $4,421,269 35,204
2025-03-31 $4,699,084 34,340
2024-12-31 $5,121,290 33,490
2024-09-30 $6,441,108 33,229
2024-06-30 $9,732,035 41,981
2024-03-31 $9,812,673 45,507
2023-12-31 $13,154,830 50,836
2023-09-30 $12,459,329 48,478
2023-06-30 $20,597,503 72,310
2023-03-31 $18,744,503 67,419
2022-12-31 $10,672,773 38,541
2022-09-30 $7,957,134 29,802
2022-06-30 $6,566,051 32,196
2022-03-31 $7,082,267 33,629
2021-12-31 $9,763,783 40,696
2021-09-30 $13,158,185 46,497
2021-06-30 $16,492,839 47,630
2021-03-31 $13,189,373 47,147
2020-12-31 $12,019,197 49,086
2020-09-30 $25,962,108 91,519
2020-06-30 $23,871,880 89,224
2020-03-31 $42,124,097 133,144